Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial.
Jardine MJ, Kotwal SS, Bassi A, Hockham C, Jones M, Wilcox A, Pollock C, Burrell LM, McGree J, Rathore V, Jenkins CR, Gupta L, Ritchie A, Bangi A, D'Cruz S, McLachlan AJ, Finfer S, Cummins MM, Snelling T, Jha V; CLARITY trial investigators.
Jardine MJ, et al. Among authors: snelling t.
BMJ. 2022 Nov 16;379:e072175. doi: 10.1136/bmj-2022-072175.
BMJ. 2022.
PMID: 36384746
Free PMC article.
Clinical Trial.